Diligence memo · auto-generated · as of July 3, 2026

Healthfinch, Inc.

Healthfinch, Inc. looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Healthfinch, Inc. operates in Healthtech, based in MADISON.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Healthfinch, Inc. has raised $15M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $7.3M on 2015-12-18.

Most recent recorded round closed around 2018-03-23.

Valuation (modeled)modeled

Provath models Healthfinch, Inc. at approximately $130M (range $7.4M–$705M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.97× the median modeled value of Series A Healthtech companies in 2016–2018 (103 peers) — value vs value, same stage and era. Within the normal band (97% of peer median) for its niche.

Financing rhythm & timingmixed

Historic cadence: a new round about every 18 months.

Last raise 8.3 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 1.3× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 76% of Healthtech peers (2138 compared).

Modeled value ranks above 81% of those peers.

Closest niche peers: Prenexus Health, LLC, HealthMyne, Inc., Companion Medical, Inc., Health at Scale Corp, Motus GI Medical Technologies, Ltd..

Peoplefiled

10 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.